NCT04344184View on ClinicalTrials.gov

SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

June 10, 2022

Study Completion Date

June 10, 2022

Conditions
COVID-19Lung Injury, AcuteKidney Injury
Interventions
DRUG

L-ascorbic acid

50 mg/kg intravenous vitamin C infusion every 6 hours for up to 96 hours

OTHER

Placebo

Dextrose 5% Water

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT04344184 - SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI) | Biotech Hunter | Biotech Hunter